Honorable mentions go to the Teams from the MAZ CVICU (second place) and the Misericordia ICU (third place).
On behalf of all PEPTIC investigators and study personnel, we would like to extend a special thanks to all teams from all 8 participating ICUs.
Thanks to your efforts, Alberta will contribute data on over 4000 patients to this worldwide study. This has been a major accomplishment and hopefully the seed for more opportunities for similarly designed pragmatic trials in the future.
On behalf of all PEPTIC investigators and study personnel, we would like to extend a special thanks to all teams from all 8 participating ICUs.
Thanks to your efforts, Alberta will contribute data on over 4000 patients to this worldwide study. This has been a major accomplishment and hopefully the seed for more opportunities for similarly designed pragmatic trials in the future.